Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Fact.mr
www.factmr.com/
James Jones
info@factmr.com
35316111593
Suite 9884 27 Upper Pembroke Street, Dublin 2


Bookmark and Share
Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive
A lately compiled research analysis on the drug eluting balloon catheter market unveil that ever-increasing healthcare expenditure, burgeoning geriatric demographic, enhanced reimbursement support by governments will account for the augmentation of t

BriefingWire.com, 4/17/2019 - Drug eluting balloons (DEB), one of the newest medical devices, have become popular as it is used for treating coronary artery diseases. In addition, patients who find difficult to undergo percutaneous coronary intervention (PCI) procedures opt for drug eluting balloon catheter. Consequently, drug eluting balloon catheter manufacturers have upped their production capacity. In a bid to expand its market penetration, companies vie to manufacture cost-effective catheters. Rising cases of cardiology intervention and rampant cardiovascular diseases have further signified the importance of drug eluting balloon catheter.

The emergence of new-generation drug eluting balloon catheters have opened avenue for stakeholders and manufacturers in the market. Moreover, in order to accentuate its utility, massive investments in research and development pipelines have been witnessed. Growing number of companies are gradually shifting towards manufacturing drug eluting balloon catheters as it has turned out be viable and efficient vis-à-vis balloon angioplasty or stenting.

Request Sample Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=146

A lately compiled research analysis on the drug eluting balloon catheter market unveil that ever-increasing healthcare expenditure, burgeoning geriatric demographic, enhanced reimbursement support by governments will account for the augmentation of the drug eluting balloon catheter.

However, DEB do face daunting challenge rom drug eluting stents (DES) for the treatment of coronary artery disease. Though clinical application of drug eluting stents has significantly lessened the incidence of in-stent restenosis, delayed stent thrombosis and malapposition does not augur fare well with DES. On account of complications associated with DES, drug eluting balloon catheter was designed to negate insertion of a permanent foreign object in the blood vessel.

By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market.

Drug Eluting Balloon Catheter Market: Overview

The report provides an exhaustive analysis on the market for drug eluting balloon catheter for the assessment period 2018-2026. The report further sheds light on the dynamics of the drug eluting balloon catheter market which significantly impact the growth of the market.

Furthermore, the report delves into the segregation of the market which is will provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.

Browse Full Report with TOC:

www.factmr.com/report/146/drug-eluting-balloon-catheter-market

The report also focuses on the epidemiology and product mapping behavior on the basis of region. The report also incorporates average pricing analysis and sheds light on supply chain. Assessment of the drug eluting balloon catheter market incorporates provision of relevant market numbers and regional assessment of major factors. The report also includes regional and country-wise assessment.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.